Client: Apposite Capital, experienced private equity and venture capital investors dedicated to life sciences and healthcare
- Apposite Capital were considering co-investment in a West Coast US biotech company, Anaphore. Ithaka was employed to conduct due diligence, providing an opinion on aspects of a novel therapeutic platform as an alternative to antibody-based therapeutics.
- Apposite Capital, 5AM Ventures and Versant Ventures led a $25M investment in Anaphore.
- The client was considering investment in a recent start-up aiming to deliver a significant reduction in manufacturing costs for drugs based on antibodies or antibody-drug conjugates. Ithaka performed technical and commercial due diligence, addressing the market opportunity, the competitive position, the proposed business model, the technical feasibility of the products and services, and the development plan.
- The client made a significant initial investment into the business.